Cargando…

Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies

Detalles Bibliográficos
Autores principales:	Tse, Ka Yu, Liu, Jihong, Lee, Sung-Jong, Tan, David S. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996443/ https://www.ncbi.nlm.nih.gov/pubmed/35419284 http://dx.doi.org/10.3389/fonc.2022.882925

Ejemplares similares

Editorial: The role of imaging in gynecological malignancies
por: Han, Kathy, et al.
Publicado: (2023)

Editorial: Advances of Targeted Therapy in Gynecologic Malignancies
por: Qiu, Haifeng, et al.
Publicado: (2022)

Editorial: Molecular predictive pathology in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2023)

Harnessing immunomodulation during DNA damage in Ewing sarcoma
por: Daley, Jessica D., et al.
Publicado: (2022)

Editorial: Diagnosis and treatment of gynecologic malignancies during pregnancy
por: Wang, Yudong, et al.
Publicado: (2023)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Editorial: Grappling with the Multifaceted World of the DNA Damage Response
por: Porro, Antonio
Publicado: (2016)

Disparities in Gynecological Malignancies
por: Chatterjee, Sudeshna, et al.
Publicado: (2016)

Editorial: Methods in gynecological oncology
por: Perelli, Federica, et al.
Publicado: (2023)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Editorial: Harnessing the Power of Patient Derived Models of Cancer
por: Pine, Sharon R., et al.
Publicado: (2018)

Editorial: Women in gynecological oncology 2021
por: Virarkar, Mayur, et al.
Publicado: (2023)

SOX9: Advances in Gynecological Malignancies
por: Chen, Huan, et al.
Publicado: (2021)

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
por: Valvo, Victoria, et al.
Publicado: (2023)

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies
por: Reinbolt, Raquel E., et al.
Publicado: (2013)

Toward an Improved Understanding of the Ionizing Radiation Induced DNA Damage/Response Networks in Human Malignancies
por: Haas-Kogan, Daphne A., et al.
Publicado: (2014)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: New Development of Tracers Uses in Gynecologic Surgery
por: Cianci, Stefano, et al.
Publicado: (2022)

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases
por: Turchi, John J., et al.
Publicado: (2022)

Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
por: Xuan, Jiachen, et al.
Publicado: (2021)

Editorial: Future Perspectives of Sentinel Node Mapping in Gynecological Oncology
por: Santoro, Angela, et al.
Publicado: (2022)

Editorial: New molecular approaches to improve gynecological cancer management
por: Abreu, Miguel Henriques, et al.
Publicado: (2023)

Harnessing DNA Double-Strand Break Repair for Cancer Treatment
por: Trenner, Anika, et al.
Publicado: (2019)

MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies
por: Duică, Florentina, et al.
Publicado: (2020)

The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
por: Marinelli, Oliviero, et al.
Publicado: (2019)

Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
por: Villegas-Pineda, Julio César, et al.
Publicado: (2023)

Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022)

Pulmonary side effects of nivolumab in a patient treated for gynecological malignancy
por: Ip, Joana, et al.
Publicado: (2018)

The DNA damage response in mammalian oocytes
por: Carroll, John, et al.
Publicado: (2013)

C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage
por: Yang, Zhikuan, et al.
Publicado: (2019)

Editorial: The management of hematologic malignancies in lower-income countries
por: Ganesan, Prasanth, et al.
Publicado: (2023)

Harnessing Lactate Metabolism for Radiosensitization
por: Liu, Kevin X., et al.
Publicado: (2021)

CRL Ubiquitin Ligases and DNA Damage Response
por: Li, Ju-Mei, et al.
Publicado: (2012)

BRCA1 in the DNA damage response and at telomeres
por: Rosen, Eliot M.
Publicado: (2013)

Regulation of the DNA damage response by ubiquitin conjugation
por: Brinkmann, Kerstin, et al.
Publicado: (2015)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies
por: Kunos, Charles A., et al.
Publicado: (2012)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16o18v4t875uvlt0r7ul71hhmt